Clinical effects of periodontal therapy on the severity of cyclosporin A-induced gingival hyperplasia

Journal of Periodontology

Volumn 70, Issue 6, 1999, Pages 587-593

  Kantarci, Alpdoǧan ^a   Cebeci, Irfan ^a   Tuncer, Özen ^a   Çarin, Mahmut ^b   Firatli, Erhan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE

Author keywords

Cyclosporin A adverse effects; Gingiva hyperplasia etiology; Gingival hyperplasia therapy; Periodontal disease therapy

Indexed keywords

CYCLOSPORIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CURETTAGE; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; FEMALE; FIBROSIS; GINGIVA HYPERPLASIA; GINGIVECTOMY; GINGIVITIS; GRAFT REJECTION; HUMAN; MALE; MOUTH HYGIENE; ORAL DRUG ADMINISTRATION; PERIODONTAL DISEASE; PERIODONTICS; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE;

ADULT; CYCLOSPORINE; DENTAL CARE FOR CHRONICALLY ILL; DENTAL SCALING; FEMALE; GINGIVAL HYPERPLASIA; GINGIVITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; ORAL HYGIENE; PERIODONTAL INDEX; SUBGINGIVAL CURETTAGE;

EID: 0033013523     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1999.70.6.587     Document Type: Article

References (45)

1. Borel JF, Feurer C, Gubler HU. Biological effects of cyclosporin A: A new antilymphocyte agent. Agents Actions 1976;6:468-475.
2. Calne RY, Rolles K, White DJG, et al. Cyclosporin-A in clinical organ grafting. Transplant Proc 1981;13:349-358.
3. Faulds D, Goa KL, Benfield P. Cyclosporin: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 1993;45:953-1040.
4. Klintmalm G, Iwatsuki S, Starzl TE. Cyclosporin A hepatoxicity in 66 renal allograft recipients. Transplantation 1981;32:488-489.
5. Hamilton DV, Evans DB, Thiru S. Toxicity of Cyclosporin A in organ grafting. In: White DJG, ed. Cyclosporin A. Amsterdam: Elsevier;1982:393-411.
6. Laupacis A, Keown PA, Ulan RA, McKenzie N, Stiller CR. Cyclosporin A: A powerful immunosuppressant. Canad Med Assoc J 1982;126:1041-1046.
7. Palestine AG, Nussenblatt RB, Chan C-C. Side effects of systemic cyclosporine in patients not undergoing transplantation. Am J Med 1984;77:652-656.
8. Rateitschak-Plüss EM, Hefti A, Lörtscher R, Thiel G. Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Periodontol 1983;10:237-246.
9. Tyldesley WR, Rotter E. Gingival hyperplasia induced by cyclosporin-A. Br Dent J 1984;157:305-309.
10. Friskopp J, Klintmalm G. Gingival enlargement. A comparison between cyclosporine and azathioprine treated renal allograft recipients. Swed Dent J 1986;10:85-92.
11. Wysocki GP, Gretzinger HA, Laupacis A, Ulan RA, Stiller CR. Fibrous hyperplasia of the gingiva: A side effect of cyclosporin A therapy. Oral Surg Oral Med Oral Pathol 1983;55:274-278.
12. Adams D, Davies G. Gingival hyperplasia associated with Cyclosporin A: A report of two cases. Br Dent J 1984;157:89-90.
13. Daley TD, Wysocki GP, May C. Clinical and pharmacological correlations in cyclosporin-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1986;62:417-421.
14. Rostock MH, Fry HR, Turner JE. Severe gingival overgrowth associated with cyclosporine therapy. J Periodontol 1986;57:294-299.
15. McGaw T, Lam S, Soates J. Cyclosporin-induced gingival overgrowth: Correlation with dental plaque scores, gingivitis scores, and cyclosporin levels in serum and saliva. Oral Surg Oral Med Oral Pathol 1987;64:293-297.
16. Seymour RA, Smith DG, Rogers SR. The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patient. A longitudinal study. J Clin Periodontol 1987;14:610-613.
17. Daly CG. Resolution of cyclosporin A (CsA)-induced gingival enlargement following reduction in CsA dosage. J Clin Periodontol 1992;19:143-145.
18. Pernu HE, Hannele Pernu LM, Huttunen KR, Nieminen PA, Knuuttila MLE. Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol 1992;63:548-553.
19. Pernu HE, Knuuttila MLE, Huttunen KR, Tilikainen ASK. Drug-induced gingival overgrowth and Class II major histocompatibility antigens. Transplantation 1994;57:1811-1813.
20. Thomason JM, Seymour RA, Rice N. The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. J Clin Periodontol 1993;20:37-40.
21. Hassell TM, Burtner AP, McNeal D, Smith RG. Oral problems and genetic aspects of individuals with epilepsy. Periodontol 2000 1994;6:68-78.
22. Hefti AF, Eshenaur AE, Hassell TM, Stone C. Gingival overgrowth in cyclosporine A treated multiple sclerosis patients. J Periodontol 1994;65:744-749.
23. Somacarrera ML, Hernandez JA, Moskow BS. Factors related to the incidence and severity of cyclosporin-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 1994;65:671-675.
24. Thomason JM, Seymour RA, Ellis JS, et al. Iatrogenic gingival overgrowth in cardiac transplantation. J Periodontol 1995;66:742-746.
25. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Cliin Periodontol 1996;23:107-110.
26. Nishikawa S, Nagata T, Oka T, Ishida H. Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model. J Periodontol 1996;67:548-553.
27. Cebeci I, Kantarci A, Firatli E, et al. Evaluation of the frequency of HLA determinants in patients with gingival overgrowth induced by cyclosporine-A. J Clin Periodontol 1996;23:737-742.
28. Cebeci I, Kantarci A, Firatli E, Çarin M, Tuncer O. The effect of verapamil on the prevalence and the severity of cyclosporine-induced gingival overgrowth among renal allograft recipients. J Periodontol 1996;67:1201-1205.
29. Cebeci I, Kantarci A, Gürel N, et al. Analysis of peripheral blood leukocytes in patients with cyclosporine-A induced gingival overgrowth. J Periodontol 1998;69:1435-1439.
30. Dill RE, Miller EK, Weil T, Lesley S, Farmer GR, Iacopino AM. Phenytoin increases gene expression for platelet-derived growth factor B chain in macrophages and monocytes. J Periodontol 1993;64:169-173.
31. Williamson MS, Miller EK, Plemons JM, Rees T, Iacopino AM. Cyclosporine A upregulates interleukin-6 gene expression in human gingiva: Possible mechanism for gingival overgrowth. J Periodontol 1994;65:895-903.
32. Plemons JM, Dill RE, Rees TD, Dyer BJ, Ng MC, lacopino AM. PDGF-B producing cells and PDGF-B gene expression in normal gingiva and cyclosporine A-induced gingival overgrowth. J Periodontol 1996;67: 264-270.
33. Nares S, Ng MC, Dill RE, Park B, Cutler CW, Iacopino AM. Cyclosporine A upregulates platelet-derived growth factor B chain in hyperplastic human gingiva. J Periodontol 1996;67:271-278.
34. Iacopino AM, Doxey D, Cutler CW, et al. Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: Possible molecular mechanism of drug-induced gingival hyperplasia. J Periodontol 1997;68:73-83.
35. Atilla G, Kütükçüler N. Crevicular fluid interleukin-1ß, tumor necrosis factor-α, and interleukin-6 levels in renal transplant patients receiving cyclosporine-A. J Periodontol 1998;69:784-790.
36. Marshall RI, Bartold PM. Medication induced gingival overgrowth. Oral Dis 1998;4:130-151.
37. Hassell TM, Hefti AF. Drug-induced gingival overgrowth: Old problem, new problem. Crit Rev Oral Biol Med 1991;2:103-107.
38. Bartold PM. Cyclosporine and gingival overgrowth. J Oral Pathol 1987;16:464-468.
39. Seymour RA, Smith DG. The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 1991;18:107-110.
40. Pernu HE, Hannele Pernu LM, Knuuttila LE. Effect of periodontal treatment on gingival overgrowth among cyclosporine A-treated renal transplant recipients. J Periodontol 1993;64:1098-1100.
41. Seymour RA, Smith DG, Turnbull DN. The effect of phenytoin and sodium valproate on the periodontal health of adult epileptic patients. J Clin Periodontol 1985;12:413-419.
42. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
43. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21: 533-551.
44. Carranza FA Jr. Gingival curettage. In: Carranza FA Jr., Newman MG, eds. Clinical Periodontology. Philadelphia: WB Saunders Company; 1996:584-587.
45. Bullon P, Machuca G, Martinez-Sahuquillo A, et al. Evaluation of gingival and periodontal conditions following causal periodontal treatment in patients treated with nifedipine and diltiazem. J Clin Periodontol 1996;23:649-657.